Maker of fizzy orange tablet settles with feds after cold-cure boasts
(NEWSER) - Airborne—the fizzy orange tablet long pitched as a way to cure and prevent the common cold—will refund consumers the price of up to six purchases because it has no evidence to back up those claims, the Washington Post reports. Under a deal cut yesterday, the company will add $6.5 million to the $23.5 million it agreed to pay earlier this year in a class-action lawsuit. More»
